Hypera SA (HYPMY)
3.96
-0.24
(-5.71%)
USD |
OTCM |
Jun 08, 16:00
Hypera EPS Diluted (Quarterly) : 0.1032 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 65.77M |
| Revenue (Quarterly) | 383.88M |
| Total Expenses (Quarterly) | 318.01M |
| Enterprise Value | 4.014B |
| Gross Profit Margin (Quarterly) | 57.33% |
| Profit Margin (Quarterly) | 17.13% |
| Earnings Yield | 12.14% |
| Operating Earnings Yield | 17.67% |
| Normalized Earnings Yield | 12.14 |